Xi Li
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Gravity-Driven Formation of Water-in-Wax Spheres for Efficient One-Pot CRISPR Diagnostics.
Journal: ACS nano
Published: February 26, 2026
Dual blockades of TIM-3 and PD-1 effectively prevent hyper-progression and enhance the efficacy of anti-PD-1 therapy in high-grade serous ovarian cancer.
Journal: Cell death & disease
Published: May 20, 2025
Inhibiting the IRE1α Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 28, 2021
Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis.
Journal: Cell reports. Medicine
Published: November 22, 2021
The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian Cancer.
Journal: Frontiers in immunology
Published: October 21, 2021
AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway.
Journal: Cancer letters
Published: July 29, 2021
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway.
Journal: The Journal of experimental medicine
Published: April 10, 2021
Clinical characteristics and survival of patients with normal-sized ovarian carcinoma syndrome: Retrospective analysis of a single institution 10-year experiment.
Journal: World journal of clinical cases
Published: June 28, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026